Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Arthritis
>>
Eli Lilly
>>
Phase 3
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
tabalumab
(LY2127399) / Eli Lilly
Taltz
(ixekizumab) / Eli Lilly, Japan Tobacco
Olumiant
(baricitinib) / Incyte, Eli Lilly
Raylumis
(tanezumab) / Eli Lilly, Pfizer
